The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aclaris Therapeutics, Inc. | COM | 00461U105 | 19,817,327 | 1,258,243 | SH | SOLE | 1,258,243 | 0 | 0 | |||
| Adicet Bio, Inc. | COM | 007002108 | 4,994,206 | 558,636 | SH | SOLE | 558,636 | 0 | 0 | |||
| Compass Therapeutics, Inc. | COM | 20454B104 | 22,132,000 | 4,400,000 | SH | SOLE | 4,400,000 | 0 | 0 | |||
| Disc Medicine, Inc. | COM | 254604101 | 4,843,454 | 243,513 | SH | SOLE | 243,513 | 0 | 0 | |||
| Hims & Hers Health, Inc. | COM CL A | 433000106 | 25,905,265 | 4,041,383 | SH | SOLE | 4,041,383 | 0 | 0 | |||
| Kinnate Biopharma Inc. | COM | 49705R105 | 5,337,506 | 875,001 | SH | SOLE | 875,001 | 0 | 0 | |||
| Pardes Biosciences Inc | COM | 69945Q105 | 16,964,110 | 10,037,935 | SH | SOLE | 10,037,935 | 0 | 0 | |||
| Pharvaris N.V. | COM | N69605108 | 384,098 | 34,142 | SH | SOLE | 34,142 | 0 | 0 | |||
| Quantum-Si Incorporated | COM CL A | 74765K105 | 1,691,614 | 924,379 | SH | SOLE | 924,379 | 0 | 0 | |||
| Somalogic, Inc. | COM CL A | 83444K105 | 8,826,345 | 3,516,472 | SH | SOLE | 3,516,472 | 0 | 0 | |||
| Theseus Pharmaceuticals, Inc. | COM | 88369M101 | 17,855,023 | 3,585,346 | SH | SOLE | 3,585,346 | 0 | 0 | |||